The impact of IMS Health Korea’s prosecution raises concerns of domestic pharmaceutical companies

As the pharmaceutical-related information provider, IMS Health Korea, is prosecuted for illegally collecting information, such as patient treatment records and prescription information, domestic pharmaceutical companies are expected receive considerable impacts.

The Personal Information Criminal Investigation Department found suspicion of sending illegally acquired patient information to its h...